By Dr. Peter Vanderklish
Many neurological disorders appear very different clinically, yet an important biological theme is emerging across them: early loss of synaptic connectivity.
In a recent article published in The Scientist, Dr. Vanderklish, Chief Science Officer at Spinogenix, examines synapse loss as a point of convergence across conditions including Alzheimer’s disease, amyotrophic lateral sclerosis, and schizophrenia.
The article outlines the scientific rationale for regenerative approaches aimed at restoring synaptic structure and function, and what that could mean for the future of neurological therapeutics.
Read the full article in The Scientist: https://www.the-scientist.com/regenerating-synapses-could-help-treat-neurodegenerative-diseases-74149